Studies on the cytotoxic, apoptotic and antitumoral effects of Au(III) and Pt(II) complexes of 1, 10-phenanthroline on V79 379A and A549 cell lines

References

• Desoize B. Cancer and metals and metal compounds: Part II–cancer treatment. Crit Rev Oncol Hematol 2002;42:213–215.
   PubMed Web of Science ®Google Scholar
• Ott I, Gust R. Non platinum metal complexes as anti-cancer drugs. Arch Pharm (Weinheim) 2007;340:117–126.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu L, Gong Y, Zheng X, Yang M, Cui J et al. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes. Eur J Med Chem 2009;44:2322–2327.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gong Y, Zheng X, Yang M, Cui J. Synthesis, cytotoxicity and DNA binding levels of tri-functional mononuclear platinum(II) complexes. Eur J Med Chem 2008;43:441–447.
   PubMed Web of Science ®Google Scholar
• Barbara C, Orlandi P, Bocci G, Fioravanti A, Di Paolo A, Natale G et al. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma. Eur J Pharmacol 2006;549:27–34.
   PubMed Web of Science ®Google Scholar
• Fai To Y, Wai-Yin Sun R, Chen Y, Sau-Fong Chan V, Yu W, Tam PK, Che C, Lin CS. Gold(III) porphyrin complex is more potent than cisplatin in inhibiting growth of nasopharyngeal carcinoma in vitro and in vivo. Int J Cancer 2009;124:1971–1979.
   PubMed Web of Science ®Google Scholar
• Wang Y, He QY, Sun RW, Che CM, Chiu JF. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead. Eur J Pharmacol 2007;554:113–122.
   PubMed Web of Science ®Google Scholar
• Zhang CX, Lippard SJ. New metal complexes as potential therapeutics. Curr Opin Chem Biol 2003;7:481–489.
   PubMed Web of Science ®Google Scholar
• Michalke B. Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs. J Trace Elem Med Biol 2010;24:69–77.
   PubMed Web of Science ®Google Scholar
• Sun RW, Che C. The anti-cancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands. Coordin Chem Rev 2009;253;1682–1691.
   Web of Science ®Google Scholar
• Gabbiani C, Casini A and Messori L. Gold (III) compounds as anticancer drugs. Gold Bulletin 2007;40:73–81.
   Web of Science ®Google Scholar
• Maiore L, Cinellu MA, Michelucci E, Moneti G, Nobili S, Landini I et al. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. J Inorg Biochem 2011;105:348–355.
   PubMed Web of Science ®Google Scholar
• Marcon G, Carotti S, Coronnello M, Messori L, Mini E, Orioli P et al. Gold(III) complexes with bipyridyl ligands: Solution chemistry, cytotoxicity, and DNA binding properties. J Med Chem 2002;45:1672–1677.
   PubMed Web of Science ®Google Scholar
• Cusumano M, Di Pietro ML, Giannetto A. DNA interaction of platinum(II) complexes with 1,10-phenanthroline and extended phenanthrolines. Inorg Chem 2006;45:230–235.
   PubMed Web of Science ®Google Scholar
• Bencini A, Lippolis V. 1,10-phenanthroline: A versatile building block fort he construction of ligands for various purposes. Coordin Chem Rev 2010;254:2096–2180.
   Web of Science ®Google Scholar
• Zhao G, Sun H, Lin H, Zhu S, Su X, Chen Y. Palladium(II) complexes with N,N’-dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, characterization and cytotoxic activity. J Inorg Biochem 1998;72:173–177.
   PubMed Web of Science ®Google Scholar
• Beynek N, Uluçam G, Benkli K, Koparal AT. Synthesis and characterization of new binaphthyl-linked phenanthroline-, bipyridine-, or pyridine-derived ligands, and the study of their cytotoxic activity. Helv Chim Acta 2008;91:2089–2096.
   Web of Science ®Google Scholar
• Li WY, Chan SW, Guo DJ, Chung MK, Leung TY, Yu PH. Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines. J Ethnopharmacol 2009;124:251–256.
   PubMed Web of Science ®Google Scholar
• Altinoz MA, Bilir A, Ozar E, Onar FD, Sav A. Medroxyprogesterone acetate alone or synergistic with chemotherapy suppresses colony formation and DNA synthesis in C6 glioma in vitro. Int J Dev Neurosci 2001;19:541–547.
   PubMed Web of Science ®Google Scholar
• Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F et al. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol 2010;79:90–101.
   PubMed Web of Science ®Google Scholar
• Kemp DC, Brouwer KL. Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure. Toxicol In Vitro 2004;18:869–877.
   PubMed Web of Science ®Google Scholar
• Mossman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Bae SN, Lee YS, Kim MY, Kim JD, Park LO. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR®) on human epithelial ovarian cancer cell line, OVCAR-3. Gynecol Oncol 2006;103:127–136.
   PubMed Web of Science ®Google Scholar
• Tong D, Poot M, Hu D, Oda D. 5-Fluorouracil-induced apoptosis in cultured oral cancer cells. Oral Oncol 2000;36:236–241.
   PubMed Web of Science ®Google Scholar
• Nell MJ, Wagener JM, Zeevaart JR, Kilian E, Mamo MA, Layh M et al. The anti-tumour properties and biodistribution (as determined by the radiolabeled equivalent) of Au-compounds intended as potential chemotherapeutics. Appl Radiat Isot 2009;67:1370–1376.
   PubMed Web of Science ®Google Scholar
• Ponticalli G. Synthesis, characterization, structure and cytotoxic activity of gold(III) complexes with amidrazone derivatives. Transit Metal Chem 2006;31:703–707.
   Web of Science ®Google Scholar
• Abbate F, Oriolli P, Bruni B, Marcon G, Messori L. Crystal structure and solution chemistry of the cytotoxic complex 1,2-dichloro(0-phenanthroline)gold(III) chloride. Inorg Chim Acta 2000;311:1–5.
   Web of Science ®Google Scholar
• Wesselinova D, Neykov M, Kaloyanov N, Toshkova R, Dimitrov G. Antitumour activity of novel 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives. Eur J Med Chem 2009;44:2720–2723.
   PubMed Web of Science ®Google Scholar
• Wang S, Shao W, Li H, Liu C, Wang K, Zhang J. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives. Eur J Med Chem 2011;46:1914–1918.
   PubMed Web of Science ®Google Scholar
• Deegan C, McCann M, Devereux M, Coyle B, Egan DA. In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells. Cancer Lett 2007;247:224–233.
   PubMed Web of Science ®Google Scholar
• Kosmider B, Zyner E, Osiecka R, Ochocki J. Induction of apoptosis and necrosis in A549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP. Mutat Res 2004;563:61–70.
   PubMed Web of Science ®Google Scholar
• Reedijk J. Medicinal Applications of metal complexes binding to biological macromolecules. Macromol Symp 2008;270:193–201.
   Google Scholar
• Wang Y, He QY, Che CM, Tsao SW, Sun RW, Chiu JF. Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways. Biochem Pharmacol 2008;75:1282–1291.
   PubMed Web of Science ®Google Scholar